Acrobiosystems Co.,Ltd.(301080),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

301080 Acrobiosystems Co.,Ltd.

Closed 11-02 15:00:00

101.57

-1.93

-1.86%

High103.75	Low90.88	Vol20.34M
Open97.50	D1 Closing103.50	Amplitude12.43%
Mkt Cap17.06B	Tradable Cap12.90B	Total Shares168.00M
T/O1.97B	T/O Rate16.02%	Tradable Shares127.00M
P/B6.32	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"301080","market":"SZ","secType":"STK","nameCN":"Acrobiosystems Co.,Ltd.","latestPrice":101.57,"timestamp":1793603037000,"preClose":103.5,"halted":0,"volume":20341407,"delay":0,"changeRate":-0.0186,"floatShares":127000000,"shares":168000000,"eps":1.1614,"marketStatus":"Closed","change":-1.93,"latestTime":"11-02 15:00:00","open":97.5,"high":103.75,"low":90.88,"amount":1966000000,"amplitude":0.1243,"askPrice":101.57,"askSize":52,"bidPrice":101.56,"bidSize":47,"shortable":0,"etf":0,"ttmEps":1.1614,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793669400000},"marketStatusCode":5,"adr":0,"adjPreClose":103.5,"symbolType":"stock","openAndCloseTimeList":[[1793583000000,1793590200000],[1793595600000,1793602800000]],"highLimit":113.85,"lowLimit":93.15,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":167679058,"isCdr":false,"pbRate":6.32,"roa":"--","peRate":87.454796,"roe":"5.96%","epsLYR":0.9889,"committee":-0.353846,"marketValue":17031000000,"turnoverRate":0.1604,"status":1,"floatMarketCap":12883000000},"requestUrl":"/m/hq/s/301080","defaultTab":"news","newsList":[{"id":"1116869441","title":"ACROBIOSYSTEMS Reports First Three Quarters Results: Net Profit Attributable to Shareholders Reaches 162 Million Yuan, Up 22.02% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1116869441","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116869441?lang=en_us&edition=fundamental","pubTime":"2026-10-27 00:26","pubTimestamp":1793031969,"startTime":"0","endTime":"0","summary":"ACROBIOSYSTEMS (301080.SZ) has released its financial report for the third quarter of 2026.In the first three quarters, the company achieved operating revenue of 801 million yuan, representing a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176399757","title":"New Stock Preview: 83% Gross Margin vs 81% Reliance on Recombinant Proteins — Unpacking ACROBiosystems' \"High Margin\" and \"Single-Leg\" Dependence","url":"https://stock-news.laohu8.com/highlight/detail?id=1176399757","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176399757?lang=en_us&edition=fundamental","pubTime":"2026-10-16 15:34","pubTimestamp":1792136085,"startTime":"0","endTime":"0","summary":"There is a long-circulated metaphor in the biopharmaceutical industry — in a gold rush, the ones who reliably make money are not necessarily the gold diggers, but the water sellers. ACROBiosystems...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675944583","title":"Morgan Stanley Downgrades Acrobiosystems to Underweight from Overweight; Price Target is 75 Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2675944583","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675944583?lang=en_us&edition=fundamental","pubTime":"2026-10-15 18:07","pubTimestamp":1792058835,"startTime":"0","endTime":"0","summary":"Acrobiosystems (SHE:301080) has an average rating of overweight and mean price target of 92.56 yuan, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0216","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109895232","title":"Acrobiosystems Refiles for Hong Kong Listing, Ranks Third Among China's Biological Reagent Suppliers","url":"https://stock-news.laohu8.com/highlight/detail?id=1109895232","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109895232?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:20","pubTimestamp":1790904028,"startTime":"0","endTime":"0","summary":"According to disclosures made by the Hong Kong Stock Exchange on Sept. 30, Beijing Acrobiosystems Co., Ltd. (301080.SZ) has once again submitted a listing application to the main board of the Hong...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","HEXmain","IPOS","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666568505","title":"Acrobiosystems to Invest 150 Million Yuan in Upstream Life Science, Biopharmaceutical Fund; Shares Slide 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666568505","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666568505?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:40","pubTimestamp":1789022427,"startTime":"0","endTime":"0","summary":"Acrobiosystems  will invest 150 million yuan as a limited partner in a new venture capital fund, according to a Thursday filing with the Shenzhen bourse.The amount is equivalent to 30% of the 500-million-yuan Suzhou Su-High-Tech Rongsheng ACRO Venture Capital Partnership.The fund will have a duration of eight years. It will invest in upstream life science tools and services, biopharmaceuticals, medical devices, and biomanufacturing, the filing said.The biopharmaceutical company's shares fell 9% during the afternoon session on Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139591657","title":"Acrobiosystems Posts 17.36% Profit Growth in First-Half Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1139591657","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139591657?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:48","pubTimestamp":1787935710,"startTime":"0","endTime":"0","summary":"Acrobiosystems Co., Ltd. (SZSE: 301080) has released its semi-annual report for fiscal year 2026, revealing a solid financial performance for the period.The company achieved operating revenue of RMB...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118595006","title":"Acrobiosystems Seeks HK Listing, CSRC Requests Details on Overseas Subsidiary Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1118595006","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118595006?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:39","pubTimestamp":1780054764,"startTime":"0","endTime":"0","summary":"Acrobiosystems Co.,Ltd. (301080.SZ) has been requested by the China Securities Regulatory Commission (CSRC) to provide supplementary information regarding the regulatory compliance of its overseas...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","301080","BK0216","IPOS","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123652005","title":"Acrobiosystems Concentrates on Life Sciences and Health Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1123652005","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123652005?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:32","pubTimestamp":1778675569,"startTime":"0","endTime":"0","summary":"On May 13, Acrobiosystems Co.,Ltd. responded to investor inquiries on the interactive platform, stating that the company focuses on the life sciences and health sectors, providing biological reagents such as recombinant proteins, antibodies, enzymes, and related technical services.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793619388537,"stockEarnings":[{"period":"1week","weight":0.1751},{"period":"1month","weight":-0.2663},{"period":"3month","weight":1.1393},{"period":"6month","weight":1.353},{"period":"1year","weight":0.6928},{"period":"ytd","weight":0.9477}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"北京百普赛斯生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"29203人(较上一季度增加78.47%)","perCapita":"4343股","listingDate":"2021-10-18","address":"北京市大兴区北京经济技术开发区宏达北路8号4幢4层","registeredCapital":"16767万元","survey":"　　北京百普赛斯生物科技股份有限公司的主营业务是提供重组蛋白、抗体等关键生物试剂产品及技术服务。公司的主要产品是重组蛋白、技术服务、抗体、试剂盒、磁珠。","listedPrice":112.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acrobiosystems Co.,Ltd.(301080),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Acrobiosystems Co.,Ltd.(301080) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Acrobiosystems Co.,Ltd.,301080,Acrobiosystems Co.,Ltd.股票,Acrobiosystems Co.,Ltd.股票老虎,Acrobiosystems Co.,Ltd.股票老虎国际,Acrobiosystems Co.,Ltd.行情,Acrobiosystems Co.,Ltd.股票行情,Acrobiosystems Co.,Ltd.股价,Acrobiosystems Co.,Ltd.股市,Acrobiosystems Co.,Ltd.股票价格,Acrobiosystems Co.,Ltd.股票交易,Acrobiosystems Co.,Ltd.股票购买,Acrobiosystems Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acrobiosystems Co.,Ltd.(301080),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Acrobiosystems Co.,Ltd.(301080) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction